Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-24 @ 10:58 PM
NCT ID:
NCT01426269
Eligibility Criteria:
Inclusion Criteria:
* Subject is male or female aged 18 to 80 years inclusive.
* Subject with papulopustular rosacea (11 to 40 papules or pustules) and an IGA of moderate or severe.
* For subjects using medications to treat a concurrent medical condition, type and dose must have been stable for at least 90 days prior to study entry.
Exclusion Criteria:
* Female subjects who are pregnant, nursing or planning a pregnancy during the study.
* Subject has any other active dermatological condition on the face that may interfere with the conduct of the study.
* Subject uses or has recently used any medication which may interfere with the absorption, distribution, or elimination of study medications, or may interfere with the assessments of efficacy or safety of the study medications.
* Subject has a known allergy to any of the components of the study products, and/or a known hypersensitivity to tetracyclines or metronidazole.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01426269
Study Brief:
Protocol Section:
NCT01426269